{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T19:37:07Z","timestamp":1778009827778,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[1996,1]]},"DOI":"10.1007\/bf01780666","type":"journal-article","created":{"date-parts":[[2005,6,19]],"date-time":"2005-06-19T18:19:01Z","timestamp":1119205141000},"page":"85-87","source":"Crossref","is-referenced-by-count":30,"title":["Success and failure in the treatment of acrodermatitis chronica atrophicans","Welche Therapie f\u00fchrt bei der Acrodermatitis chronica atrophicans zur Abheilung?"],"prefix":"10.1007","volume":"24","author":[{"given":"Elisabeth","family":"Aberer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Breier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Stanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01780666_CR1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2340\/0001555574424428","volume":"74","author":"I. Olsson","year":"1994","unstructured":"Olsson, I., Asbrink, E., von Stedingk, M., von Stedingk, L. V. Changes in serum IgG antibody levels toBorrelia burgdorferi in patients treated for acrodermatitis chronica atrophicans. Acta Derm. Venerol. (Stockholm) 74 (1994) 424\u2013428.","journal-title":"Acta Derm. Venerol."},{"key":"BF01780666_CR2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/JCM.27.3.545-551.1989","volume":"27","author":"K. Hansen","year":"1989","unstructured":"Hansen, K., Asbrink, E. Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans byB. burgdorferi flagellum enzyme-linked immunosorbent assay. J. Clin. Microbiol. 27 (1989) 545\u2013551.","journal-title":"J. Clin. Microbiol."},{"key":"BF01780666_CR3","first-page":"161","volume":"B 93","author":"E. Asbrink","year":"1985","unstructured":"Asbrink, E., Hovmark, A. Successful cultivation of spirochetes from skin lesions of patients with erythema chronicum migrans and acrodermatitis chronica atrophicans. Acta Pathol. Microbiol. Immunol. Sect. B 93 (1985) 161\u2013163.","journal-title":"Acta Pathol. Microbiol. Immunol. Sect."},{"key":"BF01780666_CR4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1523-1747.ep12388947","volume":"103","author":"R. Wienecke","year":"1994","unstructured":"Wienecke, R., Z\u00f6chling, N., Neubert, U., Schl\u00fcpen, E.-M., Meurer, M., Volkenandt, M. Molecular subtyping ofBorrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans. J. Invest. Dermatol. 103 (1994) 19\u201322.","journal-title":"J. Invest. Dermatol."},{"key":"BF01780666_CR5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0738-081X(93)90092-Q","volume":"11","author":"E. Asbrink","year":"1993","unstructured":"Asbrink, E. Acrodermatitis chronica atrophicans. Clin. Dermatol. 11 (1993) 369\u2013375.","journal-title":"Clin. Dermatol."},{"key":"BF01780666_CR6","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1749-6632.1988.tb31867.x","volume":"539","author":"K. Weber","year":"1988","unstructured":"Weber, K., Preac Mursic, V., Neubert, U., Thurmayr, R., Herzer, P., Wilske, B., Schierz, G., Marget, W. Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans. Ann. N.Y. Acad. Sci. 539 (1988) 324\u2013345.","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"BF01780666_CR7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF02013102","volume":"6","author":"V. Preac Mursic","year":"1987","unstructured":"Preac Mursic, V., Wilske, B., Schierz, M., Holmburger, M., S\u00fcss, E. In vitro andin vivo susceptibility ofBorrelia burgdorferi. Eur. J. Clin. Microbiol. 6 (1987) 424\u2013426.","journal-title":"Eur. J. Clin. Microbiol."},{"key":"BF01780666_CR8","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.39.5.1127","volume":"39","author":"A. Kersten","year":"1995","unstructured":"Kersten, A., Poitschek, C., Rauch, S., Aberer, E. Effects of penicillin, ceftriaxone, and doxycycline on the morphology ofBorrelia burgdorferi. Antimicrob. Agents Chemother. 39 (1995) 1127\u20131133.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01780666_CR9","doi-asserted-by":"crossref","unstructured":"Breier, F., Klade, H., Stanek, G., Poitschek, C., Kirnbauer, R., Dorda, W., Aberer, E.: Lymphoproliferative responses toB. burgdorferi in circumscribed scleroderma. Br. J. Dermatol 134 (1995) (in press).","DOI":"10.1111\/j.1365-2133.1996.tb07615.x"},{"key":"BF01780666_CR10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0732-8893(95)00027-8","volume":"21","author":"B. Schmidt","year":"1995","unstructured":"Schmidt, B., Aberer, E., Stockenhuber, C., Klade, H., Breier, F., Luger, A. Detection ofB. burgdorferi-DNA by polymerase chain reaction in the urine and breast milk of patients with Lyme borreliosis. Diagn. Microb. Infec. Dis. 21 (1995) 121\u2013128.","journal-title":"Diagn. Microb. Infec. Dis."},{"key":"BF01780666_CR11","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/archderm.1995.01690180052010","volume":"131","author":"R. R. M\u00fcllegger","year":"1995","unstructured":"M\u00fcllegger, R. R., Zoechling, N., Soyer, P., Hoedl, S., Wienecke, R., Volkenandt, M., Kerl, H. No detection ofBorrelia burgdorferi-specific DNA in erythema migrans lesions after minocycline treatment. Arch. Dermatol. 131 (1995) 678\u2013682.","journal-title":"Arch. Dermatol."},{"key":"BF01780666_CR12","unstructured":"Sigal, L. H.: Possible autoimmune mechanisms in Lyme disease. In:Schutzer, S. E. (ed.): Lyme disease: molecular and immunologic approaches. Cold Springer Harbor Laboratory Press 1992, pp. 207\u2013222."},{"key":"BF01780666_CR13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0002-9343(94)90068-X","volume":"96","author":"L. H. Sigal","year":"1994","unstructured":"Sigal, L. H. Persisting complaints attributed to chronic Lyme disease: possible mechanisms and implications for management. Am. J. Med. 96 (1994) 365\u2013374.","journal-title":"Am. J. Med."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01780666.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01780666\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01780666","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T01:04:48Z","timestamp":1706317488000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01780666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1996,1]]}},"alternative-id":["BF01780666"],"URL":"https:\/\/doi.org\/10.1007\/bf01780666","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,1]]}}}